Disclosed are bioprinted, three-dimensional, biological skin tissues comprising: a dermal layer comprising dermal fibroblasts; and an epidermal layer comprising keratinocytes, the epidermal layer in contact with the dermal layer to form the three-dimensional, engineered, biological skin tissue. Also disclosed are arrays of engineered skin tissues and methods of making engineered skin tissues.

Disclosed are bioprinted, three-dimensional, biological skin tissues comprising: a dermal layer comprising dermal fibroblasts; and an epidermal layer comprising keratinocytes, the epidermal layer in contact with the dermal layer to form the three-dimensional, engineered, biological skin tissue. Also disclosed are arrays of engineered skin tissues and methods of making engineered skin tissues.

Disclosed herein are methods of controlling a composition of M1/M2 macrophages in a wound of a subject. The method can include applying an electrospun structure to the wound, wherein the electrospun structure comprises a polymer, wherein the polymer comprises an alpha-hydroxy acid, and keeping the electrospun structure on the wound for a time period. The presence of the electrospun structure on the wound causes an increase in presence of M2 macrophages relative to M1 macrophages, which can, in turn, promote healing of the wound.

Disclosed herein are methods of controlling a composition of M1/M2 macrophages in a wound of a subject. The method can include applying an electrospun structure to the wound, wherein the electrospun structure comprises a polymer, wherein the polymer comprises an alpha-hydroxy acid, and keeping the electrospun structure on the wound for a time period. The presence of the electrospun structure on the wound causes an increase in presence of M2 macrophages relative to M1 macrophages, which can, in turn, promote healing of the wound.

A biomimetic, polymeric composite biomaterial designed as a heart valve leaflet substitute that can be used for heart valve repair and/or to fabricate a new-generation of durable heart valve prosthesis.

A first alternative to a composition for preventing or retarding degradation of a functional coating on a medical device includes an antioxidant selected from gallic acid or a derivative thereof. A second alternative to a composition for preventing or retarding degradation of a functional coating on a medical device includes carboxymethyl cellulose or a derivative or salt thereof. The use of the compositions for preventing or retarding degradation of a functional coating on a medical device from reactive species generated during exposure of radiation, and a wetting agent comprising the compositions, are also provided. The wetting agent prevents or retards the hydrolytic degradation of the coating during the intended shelf-life of the wetted coated product.

A first alternative to a composition for preventing or retarding degradation of a functional coating on a medical device includes an antioxidant selected from gallic acid or a derivative thereof. A second alternative to a composition for preventing or retarding degradation of a functional coating on a medical device includes carboxymethyl cellulose or a derivative or salt thereof. The use of the compositions for preventing or retarding degradation of a functional coating on a medical device from reactive species generated during exposure of radiation, and a wetting agent comprising the compositions, are also provided. The wetting agent prevents or retards the hydrolytic degradation of the coating during the intended shelf-life of the wetted coated product.

The present invention, in which RPE cells are suspended in a medium pharmaceutically acceptable as an ocular irrigating/washing solution and containing a poloxamer, achieves improvement of the post-thawing survival rate of cryopreserved RPE cells, improvement of the photoreceptor cell protection effect by RPE cell transplanted immediately after thawing, and prevention of loss of RPE cells in various steps from thawing to transplantation.

An approach is provided for a three-dimensional (3D) printing method for forming a 3D object. The approach provides for printing a structure of the 3D object by depositing a thermoplastic material, in which the thermoplastic material is radiolucent. The approach provides for printing one or more radio-opaque markers by depositing another material, which includes at least a radio-opaque material. The approach integrates the one or more radio-opaque markers with the structure of the 3D object.

An approach is provided for a three-dimensional (3D) printing method for forming a 3D object. The approach provides for printing a structure of the 3D object by depositing a thermoplastic material, in which the thermoplastic material is radiolucent. The approach provides for printing one or more radio-opaque markers by depositing another material, which includes at least a radio-opaque material. The approach integrates the one or more radio-opaque markers with the structure of the 3D object.